{"retracted":true,"timestamp":1397520000000,"update":{"timestamp":null,"doi":null,"pmid":24919019,"type":"retraction"},"doi":"10.1038/bjc.2014.72","journal":"British journal of cancer","publisher":null,"title":"Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies."}
